Loading stock data…
Kardigan, Inc. (KARD)
$21.60+0.75 (+3.60%)
Market ClosedLast close Sep 8
Kardigan, Inc.
Historical Price
Price (Candle)
Synthesizing Whystock Narrative...
Quarterly Financials
| Metric (USD) | Q1 2026 | Q1 2025 |
|---|---|---|
| Total Revenue | $0 | $0 |
| Gross Profit | — | — |
| Operating Income | -$58.71M↓ | -$26.08M |
| Net Income | -$56.07M↓ | -$18.02M |
Peer Comparison
JNJUNHPFE
Fundamentals
Kardigan, Inc. operates as a biopharmaceutical company focused on developing medicines for cardiovascular diseases. The company develops and provides a portfolio of medicines that target the underlying pathophysiology of cardiovascular diseases, incl...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$1.95B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Elite ROE. Management converts capital into profit efficiently.
24.65%
Volume
Today's trading volume
538,072
Recent News
2 ‘Strong Buy’ IPO Stocks JPMorgan Thinks Are Worth Watching
The IPO market has made an impressive comeback this year. Momentum began building in the first quarter and accelerated in the second, with traditional IPOs raising $114.1 billion through June 30, 2026 – roughly seven times the amount raised during the first half of 2025. SpaceX, the largest IPO in Wall Street history, understandably dominated the headlines and made Elon Musk the world’s first trillionaire, but the strength of the market extended well beyond a single blockbuster listing. AI has b
Kardigan (KARD) Stock Price At $22 Raises Fresh Valuation Questions
Kardigan (KARD), a South San Francisco based biopharmaceutical company focused on cardiovascular medicines, recently drew investor attention after its stock closed at $22.00. This price implies a market value near $1.97b. See our latest analysis for Kardigan. At a share price of $22.00, Kardigan’s 1 day share price return of 37.5% and year to date share price return of 37.5% suggest rapidly building momentum as investors reassess its cardiovascular drug pipeline and risk profile. If...
Kardigan shares soar after Nasdaq debut
Investing.com -- Kardigan Inc. shares rose iver 27% roughly one hour into its Nasdaq debut on Thursday, after the heart-health focused biotech raised $400 million in an initial public offering.
Sector Update: Healthcare Stocks Decline Thursday Afternoon
Healthcare stocks fell Thursday afternoon with the NYSE Healthcare Index decreasing 0.9% and the Sta